Prognostic value of imaging-detected immune-related adverse events in biliary tract cancer patients receiving durvalumab-based chemotherapy - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Prognostic Implications of Imaging-Identified Immune-Related Adverse Events in Patients with Biliary Tract Cancer Undergoing Durvalumab-Based Chemotherapy

  • By

  • Jeongin Yoo

  • Dong Ho Lee

  • Do-Youn Oh

  • Jeesun Yoon

  • Sang Hyub Lee

  • In Rae Cho

  • Woo Hyun Paik

  • May 28, 2026

Share

Original Source(s)

Related Content